Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Robert Q. Le, MD, PhD, J. Joseph Melenhorst, PhD, Brenna Hill, MPhil, Sarfraz Memon, MD, Minoo Battiwalla, MD, MS, Bipin N. Savani, MD, Aarthi Shenoy, MD, Nancy F. Hensel, BS, Eleftheria K. Koklanaris, RN, BS, Keyvan Keyvanfar, BS, Frances T. Hakim, PhD, Daniel C. Douek, MD, PhD, A. John Barrett, MD, FRCP, FRCPath

Blood (2010) 116 (21): 831.

https://doi.org/10.1182/blood.V116.21.831.831

Published: 2010

Journal Articles

High Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies.

J. Jopseph Melenhorst, PhD, Phillip Scheinberg, MD, Pratip K. Chattopadhyay, PhD, Emma Gostick, BS, Mario Roederer, PhD, Nancy F. Hensel, BS, Daniel C. Douek, MD, PhD, A. John Barrett, MD, David A. Price, MD, PhD

Blood (2007) 110 (11): 2763.

https://doi.org/10.1182/blood.V110.11.2763.2763

Published: 2007

Journal Articles

Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells.

J. Joseph Melenhorst, PhD, Phillip Scheinberg, MD, Emma Gostick, BS, Pratip K. Chattopadhyay, PhD, Anna Lissina, BS, David K. Cole, PhD, Mario Roederer, PhD, Ethan Bornstein, MS, Nancy F. Hensel, BS, Daniel C. Douek, MD, PhD, Andrew K. Sewell, PhD, A. John Barrett, MD, David A. Price, MD, PhD

Blood (2007) 110 (11): 1343.

https://doi.org/10.1182/blood.V110.11.1343.1343

Published: 2007

Journal Articles

PR1-Specific T Cell Responses in the First Months Following T-Cell Depleted Allogeneic Stem Cell Transplantation Occur in Both Myeloid and Non-Myeloid Malignancies but Are Only Associated with a GVL Effect in Myeloid Leukemias.

Katayoun Rezvani, MD, PhD, Yong Agnes, MD, PhD, Rhoda B. Eniafe, Stephan Mielke, MD, Bipin N. Savani, MD, David A. Price, MD, PhD, Emma Gostick, Daniel C. Douek, MD, PhD, John M. Goldman, MD, A. John Barrett, MD

Blood (2006) 108 (11): 5195.

https://doi.org/10.1182/blood.V108.11.5195.5195

Published: 2006

Journal Articles

WT1-Specific CD8+ T Lymphocytes May Participate in the Elimination of Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.

Katayoun Rezvani, MD, PhD, Agnes Yong, MD, PhD, Stephan Mielke, MD, Bipin N. Savani, MD, David A. Price, MD, PhD, Emma Gostick, Daniel C. Douek, MD, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 3679.

https://doi.org/10.1182/blood.V108.11.3679.3679

Published: 2006

Journal Articles

Acquisition of FOXP3 Expression by Human Effector CD4+ T Cells Is a Natural Consequence of Antigen Recognition.

J. Joseph Melenhorst, PhD, Phillip Scheinberg, MD, David R. Ambrozak, Nancy F. Hensel, Daniel C. Douek, MD, PhD, David A. Price, MD, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 870.

https://doi.org/10.1182/blood.V108.11.870.870

Published: 2006

Journal Articles

In Vitro Culture during Retroviral Transduction Improves Thymic Repopulation and Output after TBI and Autologous PBPC Transplantation in Rhesus Macaques.

Ruth Seggewiss, MD, Karin Lore, PhD, Javier F. Guenaga, Stefania Pittaluga, MD PhD, Mark E. Metzger, Allen Krouse, Robert E. Donahue, VMD, David Ambrozak, Daniel C. Douek, MD PhD, Cynthia E. Dunbar, MD

Blood (2004) 104 (11): 1196.

https://doi.org/10.1182/blood.V104.11.1196.1196

Published: 2004

Journal Articles

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Ruth Seggewiss, MD, Karin Lore, PhD, Elisabeth Greiner, PhD, Magnus K. Magnusson, MD, David A. Price, MD PhD, Daniel C. Douek, MD PhD, Cynthia E. Dunbar, MD, Adrian Wiestner, MD PhD

Blood (2004) 104 (11): 1342.

https://doi.org/10.1182/blood.V104.11.1342.1342

Published: 2004

NARROW

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

High Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies.

Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells.

PR1-Specific T Cell Responses in the First Months Following T-Cell Depleted Allogeneic Stem Cell Transplantation Occur in Both Myeloid and Non-Myeloid Malignancies but Are Only Associated with a GVL Effect in Myeloid Leukemias.

WT1-Specific CD8+ T Lymphocytes May Participate in the Elimination of Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.

Acquisition of FOXP3 Expression by Human Effector CD4+ T Cells Is a Natural Consequence of Antigen Recognition.

In Vitro Culture during Retroviral Transduction Improves Thymic Repopulation and Output after TBI and Autologous PBPC Transplantation in Rhesus Macaques.

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only